See the Complete Picture.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Airstrike
Aviation Accidents
South America
Military
World Cup
Parade
Donald Trump
Benjamin Netanyahu
War
Social Media
Immigration
Artificial Intelligence
Published • loading... • Updated

EGFR-TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer

Summary by Stemwell Science News
Two drug-tolerant persister lung cancer cells with different proliferative capacities were established and identified dipeptidyl peptidase 4 (DPP4) as a potential therapeutic target. [Advanced Science] Full Article
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Stemwell Science NewsStemwell Science News

EGFR-TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer

Two drug-tolerant persister lung cancer cells with different proliferative capacities were established and identified dipeptidyl peptidase 4 (DPP4) as a potential therapeutic target. [Advanced Science] Full Article

Read Full Article
curetoday.comcuretoday.com

Bringing Light to More Personalized Medicine in Lung Cancer After ASCO 2025

Expert oncologists Dr. Joshua K. Sabari and Dr. Eric K. Singhi break down key updates and takeaways in lung cancer treatment following ASCO 2025.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

curetoday.com broke the news in on Thursday, June 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Medical

Medical

News
For You
SearchBlindspotLocal